About YCC
News & Information
Education
Site Help
Contact Us

Yale Cancer Center - A Comprehensive Cancer Center Designated by the National Cancer Institute.

Patient Care
Clinical Programs
Surviving Cancer
Clinical Trials
Cancer Answers
Research
Cancer Information
Get Involved

Back to Disease List

Protocols for Gastric Cancer

HIC 0710003118
Jill Lacy M.D.
Phase II Study of FOLFOX with Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

©2006 Yale Cancer Center 333 Cedar Street, PO Box 208028, New Haven, CT 06520 Patient Advocacy and Privacy Policies